Hematologic Malignancy
Childhood Acute Leukemia
CI-CAN-00002184Explore in graph →
- NCIt
- C187056
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00002184Explore in graph →
Variants & evidence
17 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| GLIS2 Fusion1 | ||||||||
| (prognostic) | Childhood Acute Megakaryoblastic Leukemia | Prognostic | B | Supports Poor Outcome | 4 | submitted | EID8503Acute megakaryoblastic leukemia (AMKL) is a rare subtype of AML. CBFA2T3/GLIS2 and NUP98/KDM5A are recurrent aberrations, occurring in similar frequencies as RBM15/MKL1 and KMT2A-rearrangements. In th… (full text at CIViC) PMID 27114462 · de Rooij et al., 2016 · Open in CIViC | civic |
| AFDN Fusion1 | ||||||||
| (prognostic) | Childhood Acute Myeloid LeukemiaCURATED_BROADER | Prognostic | B | Supports Poor Outcome | 4 | submitted | EID8515This is a large international retrospective study of the association between fusion partner and outcome in 756 children with KMT2A-rearranged (also known as MLL-rearranged) AML from 11 study group inc… (full text at CIViC) PMID 19528532 · Balgobind et al., 2009 · Open in CIViC | civic |
| NT5C2 Mutation1 | ||||||||
| (prognostic) | Childhood Acute Lymphoblastic LeukemiaALIAS | Prognostic | B | Supports Poor Outcome | 4 | accepted | EID7818Within a cohort of 71 pediatric B-ALL relapse cases, all 7 patients with NT5C2 mutations detected at relapse demonstrated early relapse (<36 months from initial diagnosis) with a median time to relaps… (full text at CIViC) PMID 23377183 · Meyer et al., 2013 · Open in CIViC | civic |
| NT5C2 R238W3 | ||||||||
| (prognostic) | Childhood Acute Lymphoblastic LeukemiaALIAS | Prognostic | C | Supports Poor Outcome | 2 | accepted | EID786371 Childhood B-cell acute lymphocytic leukemia relapse patients had their diagnosis and relapse samples sequenced for NT5C2 mutations. Sequencing revealed 3 early relapse cases with NT5C2 R238W enrich… (full text at CIViC) PMID 23377183 · Meyer et al., 2013 · Open in CIViC | civic |
| Cytarabine + Doxorubicin + Gemcitabine + PrednisoloneSubstitutes | Childhood Acute Lymphoblastic LeukemiaALIAS | Predictive | D | Does Not Support Resistance | 4 | accepted | EID7816Overexpression of NT5C2 R238W in Reh cells resulted in no change in response to cytarabine, gemcitabine, doxorubicin or prednisolone versus wildtype or GFP controls as indicated by similar apoptosis. PMID 23377183 · Meyer et al., 2013 · Open in CIViC | civic |
| NT5C2 R367Q3 | ||||||||
| Cytarabine + Doxorubicin + Gemcitabine + PrednisoloneSubstitutes | Childhood Acute Lymphoblastic LeukemiaALIAS | Predictive | D | Does Not Support Resistance | 4 | accepted | EID7815Lentiviral mediated overexpression of NT5C2 R367Q in Reh cells resulted in no change in apoptosis after exposure to cytarabine, gemcitabine, doxorubicin, or prednisolone compared to wildtype NT5C2 ove… (full text at CIViC) PMID 23377183 · Meyer et al., 2013 · Open in CIViC | civic |
| Mercaptopurine + ThioguanineSubstitutes | Childhood Acute Lymphoblastic LeukemiaALIAS | Predictive | C | Supports Resistance | 2 | accepted | EID781271 Childhood B-cell acute lymphocytic leukemia relapse patients had their diagnosis and relapse samples sequenced for NT5C2 mutations. Sequencing revealed an early relapse case with NT5C2 R367Q enrich… (full text at CIViC) PMID 23377183 · | |
| NT5C2 S445F3 | ||||||||
| (prognostic) | Childhood Acute Lymphoblastic LeukemiaALIAS | Prognostic | C | Supports Poor Outcome | 2 | accepted | EID786471 Childhood B-cell acute lymphocytic leukemia relapse patients had their diagnosis and relapse samples sequenced for NT5C2 mutations. Sequencing revealed an early relapse case with NT5C2 S445F enrich… (full text at CIViC) PMID 23377183 · Meyer et al., 2013 · Open in CIViC | civic |
| Cytarabine + Doxorubicin + Gemcitabine + PrednisoloneSubstitutes | Childhood Acute Lymphoblastic LeukemiaALIAS | Predictive | D | Does Not Support Resistance | 4 | accepted | EID7817Overexpression of NT5C2 S445F in Reh cells resulted in no change in response to cytarabine, gemcitabine, doxorubicin or prednisolone versus wildtype or GFP controls as indicated by similar apoptosis. PMID 23377183 · Meyer et al., 2013 · Open in CIViC | civic |
| NUDT15 Inactivating Mutation1 | ||||||||
| Azathioprine + Mercaptopurine + ThioguanineSubstitutes | Childhood Acute Lymphoblastic LeukemiaALIAS | Predictive | B | Supports Adverse Response | 4 | submitted | EID7794Patients from three (Guatemala, Singapore and Japan) separate cohorts harboring NUDT15 loss of function mutations displayed intolerance to Thiopurine treatment (p=0.021, 2.1e-5, & 0.0054). Patients wi… (full text at CIViC) PMID 26878724 · Moriyama et al., 2016 · Open in CIViC | civic |
| MRTFA Fusion4 | ||||||||
| (diagnostic) | Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1ALIAS | Diagnostic | A | Supports Positive | 5 | submitted | EID8513AML (megakaryoblastic) with t(1;22)(p13.3;q13.3);RBM15-MKL1, is a defined diagnostic subgroup in the 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukem… (full text at CIViC) PMID 27069254 · Arber et al., 2016 · Open in CIViC | civic |
| 〃 | Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1ALIAS | Diagnostic | B | Supports Positive | 4 | accepted | EID12260In this study, the authors investigated the association of the RBM15::MRTFA fusion with acute megakaryoblastic leukemia (AMKL, FAB-M7), particularly in non-Down syndrome infants and young children. A… (full text at CIViC) PMID 11431691 · Ma et al., 2001 · Open in CIViC | civic |
| 〃 | ||||||||
Data updated 12 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.
| Mercaptopurine + ThioguanineSubstitutes |
| Childhood Acute Lymphoblastic LeukemiaALIAS |
| Predictive |
| D |
| Supports Resistance |
| 4 |
| accepted |
EID7813Lentiviral-mediated overexpression of NT5C2 R238W in Reh cells resulted in significant resistance against thiopurines (mercaptopurine and thioguanine) versus wildtype and GFP controls, as indicated by… (full text at CIViC) PMID 23377183 · Meyer et al., 2013 · Open in CIViC |
| civic |
| civic |
| 〃 | Childhood Acute Lymphoblastic LeukemiaALIAS | Predictive | D | Supports Resistance | 4 | accepted | EID7862Lentiviral-mediated overexpression of NT5C2 R367Q in Reh cells resulted in significant resistance against thiopurines (mercaptopurine and thioguanine) versus wildtype and GFP controls, as indicated by… (full text at CIViC) PMID 23377183 · Meyer et al., 2013 · Open in CIViC | civic |
| Mercaptopurine + ThioguanineSubstitutes |
| Childhood Acute Lymphoblastic LeukemiaALIAS |
| Predictive |
| D |
| Supports Resistance |
| 4 |
| accepted |
EID7814Lentiviral-mediated overexpression of NT5C2 S445F in Reh cells resulted in significant resistance against thiopurines (mercaptopurine and thioguanine) versus wildtype and GFP controls, as indicated by… (full text at CIViC) PMID 23377183 · Meyer et al., 2013 · Open in CIViC |
| civic |
| Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1ALIAS |
| Diagnostic |
| B |
| Supports Positive |
| 4 |
| accepted |
EID12261In this study, the authors explored the genomic landscape of acute megakaryoblastic leukemia (AMKL) in patients without Down syndrome (non-DS-AMKL). AMKL is a rare and heterogeneous subtype of acute m… (full text at CIViC) PMID 28112737 · de Rooij et al., 2017 · Open in CIViC |
| civic |
| 〃 | Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1ALIAS | Diagnostic | B | Supports Positive | 4 | accepted | EID12262In this study, the authors performed an international retrospective analysis of 490 pediatric patients (≤18 years) with non–Down syndrome acute megakaryoblastic leukemia (non-DS-AMKL), a rare and aggr… (full text at CIViC) PMID 26215111 · Inaba et al., 2015 · Open in CIViC | civic |